Sexual Health & Fertility

Table of Contents

Overview

• Sexual Health & Fertility intro
• Sexual Health & Fertility in the news
• Birth and fertility rates declining, particularly in developed markets
• Pandemic's effects on sexual activity mixed
• Female empowerment a significant growth driver

Contraception

• 2019 UN study provides insight into birth control use worldwide

Daily OC

• UN reports significant increase in daily OC use 1994-2019
• Overview of key ingredients
• Potential for category to expand outside Asia
• China's dominant brand Yasmin benefits from challenging A+P
• South Korea's market opening up via NPD
• India sees daily OC reform
• Round-up of other markets
• Switches in UK may open up European market
• Category has potential for expansion in the long term

Emergency Hormonal Contraception

• Broad geographic availability, but challenges remain
• USA dominated by single marketer
• Plan B One-Step a key player in the US market
• China's No.1 brand supported by extensive health education
• India faces challenge from widened availability of daily OC
• Italy slow to liberalise EHC market, but saw sales surge in 2021
• Germany faces growing generic competition for brands
• Plan B and ellaOne key players in other top markets
• Steady growth, with some potential for switches

Condoms

• Popular form of contraception seeing diversification of key brands
• In USA lower-tier options outperformed established leading brands
• Marketing in Brazil promotes safe and enjoyable sex
• Trojan retains commanding lead in USA thanks to focus on pleasure
• Durex has built a foundation of socially-conscious marketing
• Female condoms a growing segment

Other Contraceptives

• Spermicides available in pharmacies in certain markets
• Alternative methods generally HCP-focused

Fertility & Pregnancy

Pregnancy & Ovulation Tests

• Established category with generally high demand
• Consumerised US market maintained growth
• Clearblue an international success via many firsts
• First Response focuses on speed of results
• US innovations driven by female-led companies
• Modern Fertility focuses on building a community
• Clearblue an innovative presence in UK
• Generic competition significant in Germany
• First Response a bright spot in Australian market
• Sales in Brazil dynamic despite lack of A+P
• Generics a significant presence in France

Pregnancy & Pre-pregnancy Vitamins

• Conception through to pregnancy
• Key vitamins & their benefits
• Importance of HCPs / NPD focus
• Global trends
• USA bolstered by NPD and premium-price launches
• China finds growth despite falling birth rates
• Italy sees top tier perform well
• Germany dynamic thanks to increasing birth rate
• Mexico sees strong showing from leading brands
• Brazil's strong growth driven by two dominant brands
• Global leading brands
• Elevit global leading pregnancy vitamin range
• Femibion a key brand in Europe
• Outlook
• Male fertility VMS offers burgeoning niche

Other Fertility CHC

• Fertility lubricants: Small segment sees growing interest

FemTech

• One size does not fit all in women's health
• Clue an early entrant in FemTech segment
• Natural Cycles offers a first-in-class birth control app
• Elvie addresses breastfeeding and pelvic floor exercise
• Peptonic Medical building portfolio of FemTech brands
• Vira Health developing innovative menopause app
• Prima-Temp partners with CHC brand Enfamil
• Vivant extends FemTech apps into India and other Asian markets
• Conclusions

Sexual Health Problems

• Broad range of issues partially addressed by OTC

Erectile Dysfunction

• Most common sexual dysfunction in men
• Sildenafil-based treatments OTC in a handful of markets
• Poland boasts largest OTC market for ED treatments in 2021
• UK market created by switch of Viagra
• Viagra Connect makes OTC debut in UK
• New Zealand sees "first in world" OTC reclassification for ED
• Topical options include Futura's MED3000 ED gel
• Switch prospects
• Forecasts predict a category that could skyrocket with switches
• "Male vitality" supplements offer VMS alternative
• USA offers array of supplements for sexual performance
• Russia's sexual health supplements continue to decline
• Limited selection in other markets
• Latest launch activity offers little innovation

Premature Ejaculation

• Prevalence and treatment options
• Fortacin's EU-wide switch brings new OTC treatment

Female Sexual Dysfunction

• Complex condition slowly gaining acceptance
• Available treatment options for FSD

Sexually Transmitted Diseases

• Access to STD testing via health services commonplace
• Treatment likely to remain Rx but self testing a growing segment
• Growing number of home HIV tests in Europe
• Growing number of markets liberalising access to HIV tests myLAB BOX a key player in US STD testing
• OraQuick groundbreaking oral HIV test / Better2Know premium test kits
• SH:24 in UK bridges gap between HCPs and self-testing
• FemiClear offers relief of genital herpes symptoms
• Self-tests for chlamydia a small segment in German pharmacy market

Intimate Care

• Feminine intimate care has good global spread
• China's FIC market dominated by domestic brands
• USA's FIC growth boosted by NPD and high levels of A+P
• Honey Pot premium FIC range causing a buzz
• Large French FIC market struggled in recent years
• Italy's FIC market experiencing ups and downs
• Vagisan holds lead of German FIC despite increasing competition
• Russian FIC market expanded by NPD
• Brazil sees high levels of NPD boost FIC growth
• Poland FIC market seeing increasing crossover with sexual health
• Global FIC growth expected to accelerate as taboos break down
• VYI brands increasingly branching into FIC
• Growing trend for male intimate care

Menstruation

Period Pain

• Niche for menstrual pain growing worldwide
• In USA Midol faces growing competition from big pain relief brands
• In China MNCs fight for share with domestic TCM brands
• Japan has well-developed niche for menstrual pain
• Brazil menstrual pain segment developing rapidly
• Room for development in many key European markets
• Breaking stigma key to building the market in India

PMS

• Premenstrual syndrome and premenstrual dysphoric disorder
• Causes & symptoms of PMS
• Common ingredients to alleviate PMS
• Launch activity among branded PMS remedies
• Flo claims to be first PMS remedy in gummy format
• Consumer preference for drug-free remedies boosts sales of AZO Hormonal
• Oxaloacetate, ingredient approved for PMS symptoms

Menopause

• Herbal menopause supplements sales static globally
• China's herbal menopause supplements growing well
• New launches could expand struggling US market
• Japan's sales hit hard by Covid-19 pandemic
• European markets in need of a boost
• Mexico sees category slowly becoming more consumer-oriented
• Herbal menopause supplements in need of innovation